SCHEMBL6130162

SCHEMBL6130162

COc1ccc(Cl)cc1C1(Cl)C(=O)Nc2cc(C(F)(F)F)ccc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 1/20 0.76
KCNQ2 O43526 1/20 0.76
KCNQ4 P56696 1/20 0.76
KCNMA1 Q12791 1/20 0.76
KCNQ5 Q9NR82 1/20 0.76
CYP2C9 P11712 2/20 0.40
MAPT P10636 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 1/20 0.38
ESRRA P11474 1/20 0.37
PKM P14618 1/20 0.37
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A4 P31645 1/20 0.36
HTR2B P41595 1/20 0.36
MOGAT2 Q3SYC2 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flindokalner SCHEMBL4056222 0.86 KCNQ3 (1.00) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
Flindokalner SCHEMBL30322726 0.86 KCNQ3 (1.00) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
Flindokalner SCHEMBL5144502 0.86 KCNQ3 (1.00) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
SCHEMBL24051652 0.86 KCNQ3 (0.76) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
Flindokalner SCHEMBL4877314 0.86 KCNQ3 (1.00) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
SCHEMBL24051653 0.86 KCNQ3 (0.76) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
Flindokalner SCHEMBL29388740 0.86 KCNQ3 (1.00) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
SCHEMBL24051215 0.86 KCNQ3 (0.76) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
SCHEMBL5858002 0.85 KCNQ3 (0.74) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5
SCHEMBL24051694 0.83 KCNQ3 (0.71) KCNQ3KCNQ2KCNQ4KCNMA1KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330426-A4 SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF BRISTOL MYERS SQUIBB CO (US) 2005-09-14 EP claimed
US-20050043293-A1 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof GRIBKOFF VALENTIN K (US) 2005-02-24 US claimed
EP-1330426-A1 SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-30 EP claimed
WO-2002030868-A1 SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2002-04-18 WO claimed
US-20020045566-A1 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof BRISTOL-MYERS SQUIBB COMPANY 2002-04-18 US claimed
EP-1330426-A4 SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF BRISTOL MYERS SQUIBB CO (US) 2005-09-14 EP disclosed
US-20050043293-A1 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof GRIBKOFF VALENTIN K (US) 2005-02-24 US disclosed
EP-1330426-A1 SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-30 EP disclosed
WO-2002030868-A1 SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2002-04-18 WO disclosed